Vertex Pharmaceuticals Inc (VRTX) — Financial Flexibility Index
Vertex Pharmaceuticals Inc (VRTX) has a Financial Flexibility Index of 0.22x as of March 2026. Free cash flow of $1.56 Billion (operating CF $1.43 Billion minus capex $133.40 Million) represents 0% of total liabilities ($7.12 Billion). Also explore Vertex Pharmaceuticals Inc (VRTX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vertex Pharmaceuticals Inc Financial Flexibility Index (1991–2025)
Historical Financial Flexibility Index trend for Vertex Pharmaceuticals Inc across 35 annual periods. Check Vertex Pharmaceuticals Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vertex Pharmaceuticals Inc (1991–2025)
Year-by-year free cash flow to debt coverage for Vertex Pharmaceuticals Inc. For the full company profile including market capitalisation, see how much is Vertex Pharmaceuticals Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | $4.07 Billion | $3.63 Billion | $7.48 Billion | ▲ +1809.8% |
| 2024 | -0.03x | $-194.90 Million | $-492.60 Million | $6.12 Billion | ▼ -104.3% |
| 2023 | 0.74x | $3.80 Billion | $3.54 Billion | $5.15 Billion | ▼ -27.9% |
| 2022 | 1.02x | $4.33 Billion | $4.13 Billion | $4.24 Billion | ▲ +18.4% |
| 2021 | 0.86x | $2.88 Billion | $2.64 Billion | $3.33 Billion | ▼ -24.6% |
| 2020 | 1.15x | $3.51 Billion | $3.25 Billion | $3.06 Billion | ▲ +55.6% |
| 2019 | 0.74x | $1.64 Billion | $1.57 Billion | $2.23 Billion | ▼ -2.4% |
| 2018 | 0.75x | $1.37 Billion | $1.27 Billion | $1.81 Billion | ▲ +2.7% |
| 2017 | 0.73x | $1.10 Billion | $844.94 Million | $1.50 Billion | ▲ +290.4% |
| 2016 | 0.19x | $292.67 Million | $236.10 Million | $1.56 Billion | ▲ +182.5% |
| 2015 | -0.23x | $-320.13 Million | $-365.43 Million | $1.40 Billion | ▲ +38.9% |
| 2014 | -0.37x | $-462.00 Million | $-513.20 Million | $1.24 Billion | ▼ -202777.7% |
| 2013 | 0.00x | $-177.00K | $-51.57 Million | $962.64 Million | ▼ -100.1% |
| 2012 | 0.22x | $338.98 Million | $267.84 Million | $1.52 Billion | ▲ +15.5% |
| 2011 | 0.19x | $238.33 Million | $143.74 Million | $1.24 Billion | ▲ +139.3% |
| 2010 | -0.49x | $-597.39 Million | $-635.44 Million | $1.22 Billion | ▼ -4.0% |
| 2009 | -0.47x | $-404.09 Million | $-427.59 Million | $859.14 Million | ▼ -79.5% |
| 2008 | -0.26x | $-194.30 Million | $-226.48 Million | $741.61 Million | ▲ +60.7% |
| 2007 | -0.67x | $-220.06 Million | $-252.48 Million | $330.18 Million | ▼ -2886.4% |
| 2006 | 0.02x | $9.94 Million | $-22.48 Million | $415.64 Million | ▲ +104.8% |
| 2005 | -0.50x | $-155.09 Million | $-172.05 Million | $309.82 Million | ▼ -96.9% |
| 2004 | -0.25x | $-129.66 Million | $-142.16 Million | $510.01 Million | ▲ +10.1% |
| 2003 | -0.28x | $-150.27 Million | $-167.62 Million | $531.57 Million | ▼ -222.5% |
| 2002 | -0.09x | $-38.32 Million | $-79.54 Million | $437.14 Million | ▼ -186.0% |
| 2001 | 0.10x | $45.83 Million | $-8.07 Million | $449.78 Million | ▲ +1019.8% |
| 2000 | -0.01x | $-4.73 Million | $-16.64 Million | $427.12 Million | ▲ +98.4% |
| 1999 | -0.67x | $-15.60 Million | $-31.80 Million | $23.21 Million | ▲ +41.8% |
| 1998 | -1.15x | $-23.20 Million | $-31.10 Million | $20.10 Million | ▼ -565.4% |
| 1997 | -0.17x | $-3.40 Million | $-9.40 Million | $19.60 Million | ▲ +93.9% |
| 1996 | -2.86x | $-36.30 Million | $-40.30 Million | $12.70 Million | ▼ -269.4% |
| 1995 | -0.77x | $-10.60 Million | $-16.00 Million | $13.70 Million | ▲ +35.3% |
| 1994 | -1.20x | $-12.80 Million | $-14.70 Million | $10.70 Million | ▼ -232.3% |
| 1993 | 0.90x | $10.40 Million | $8.60 Million | $11.50 Million | ▲ +269.0% |
| 1992 | -0.54x | $-3.80 Million | $-5.30 Million | $7.10 Million | ▼ -101.7% |
| 1991 | -0.27x | $-1.30 Million | $-2.50 Million | $4.90 Million | — |